1Life Healthcare (One Medical) Announces Date of its First Quarter 2020 Results Conference Call
SAN FRANCISCO, May 01, 2020 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced that its first quarter 2020 results will be released on Wednesday, May 13, 2020, after the close of the market. The company will host a conference call on the same day at 2:00 p.m. (PT) / 5:00 p.m. (ET) to discuss its financial results.
A live audio webcast will be available online at https://investor.onemedical.com. The conference call can also be accessed by dialing 1-800-258-1651 for U.S. participants, or 1-612-979-9928 for international participants, and referencing participant code 7759975. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.
About One Medical
One Medical is a membership-based primary care platform with seamless digital health and inviting in-office care, convenient to where people work, shop, live and click. One Medical’s mission is to transform health care for all through a human-centered, technology-powered model.
Headquartered in San Francisco, 1Life Healthcare, Inc. is the administrative and managerial services company for the affiliated One Medical physician owned professional corporations that deliver medical services in-office and virtually. 1Life and the One Medical entities do business under the “One Medical” brand.
Investor Contacts:
Rose Salzwedel, One Medical
Director of Investor Relations
investor@onemedical.com
(206) 331-2211
Westwicke
Bob East or Asher Dewhurst
(443) 223-0500
onemedical@westwicke.com
Media Contact:
Kristina Skinner, One Medical
Director of External Communications
Press@onemedical.com
650-743-5187
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
